ALKERMES PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.15 USD | -1.27% |
|
+0.42% | -12.94% |
| 05-02 | UBS Adjusts Price Target on Alkermes to $21 From $23, Maintains Sell Rating | MT |
| 05-01 | Alkermes's Q1 Earnings, Revenue Grow But Miss Street View | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALKERMES PLC | Other Biotechnology & Medical Research | -1.27% | +0.42% | -12.94% | -19.98% | -2.82% | 4.09B |  |  | |
- Stock Market
- Equities
- ALKS Stock
- Charts Alkermes plc
- Relative Strength Chart
